Skip to main content
Top

Supportive Care in Cancer

Issue 4/1998

Content (15 Articles)

EDITORIAL

When dryness rules

Eduardo Bruera

Special ARTICLE

The use of unproven methods of treatment by cancer patients

Megan Miller, M. J. Boyer, Phyllis N. Butow, Melina Gattellari, Stewart M. Dunn, Annabel Childs

REVIEW ARTICLE

Constipation in advanced cancer patients

Isabelle Mancini, E. Bruera

REVIEW ARTICLE

Palliative management of brain metastases

D. Oneschuk, Eduardo Bruera

ORIGINAL ARTICLE

Prophylaxis with povidone-iodine against induction of oral mucositis by radiochemotherapy

Irenäus A. Adamietz, Rainer Rahn, Heinz D. Böttcher, Volker Schäfer, Karen Reimer, Wolfgang Fleischer

ORIGINAL ARTICLE

Suppression of heparinization of central venous catheters between cycles of chemotherapy

R. Delva, E. Gamelin, A. Lortholary, P. Maillart, P. Leynia de la Jarrige, C. Girault, J. Guérin, F. Larra

ORIGINAL ARTICLE

The impact of postchemotherapy nausea and vomiting on quality of life after moderately emetogenic chemotherapy

J. J. Rusthoven, David Osoba, Charles A. Butts, Louise Yelle, Helen Findlay, Andrew Grenville

ORIGINAL ARTICLE

Prognostic significance of febrile episodes in lung cancer patients receiving chemotherapy

T. Rikimaru, Masao Ichiki, Y. Ookubo, Kumi Matumoto, Yoshiko Mimori, Yoshiko Sueyasu, Masaharu Kinoshita, Hideki Yano, Tsuneaki Shiraishi, Kotaro Oizumi

SHORT COMMUNICATION

The Family System Test (FAST)

O. Real del Sartre, F. Stiefel, S. Leyvraz, J. Bauer, T. M. Gehring, P. Guex

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine